Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Size, Value And Growth Trajectory Through 2030
The market size for messenger ribonucleic acid (mRNA) manufacturing services has seen rapid expansion in recent years. This market is projected to expand from $6.14 billion in 2025 to $7.12 billion in 2026, at a compound annual growth rate (CAGR) of 15.9%. The historical growth can be attributed to factors such as the rise of mRNA therapeutics research, the demand for emergency vaccine manufacturing, limited in-house mRNA capacity, the proliferation of CDMO partnerships, and the expansion of biotech pipelines.
The messenger ribonucleic acid (mRNA) manufacturing service market is anticipated to experience substantial expansion over the upcoming years. By 2030, its valuation is projected to reach $12.97 billion, demonstrating a compound annual growth rate (CAGR) of 16.2%. This projected growth is driven by several factors, including the rising number of mRNA therapy trials, the growing need for contract manufacturing, advancements in personalized medicine, increased outsourcing activities by biotechnology companies, and the scaling up of commercial mRNA product development. Key trends expected during this period encompass integrated mRNA process development solutions, large-scale in vitro transcription production, comprehensive end-to-end LNP encapsulation services, swift technology transfer initiatives, and the manufacturing of GMP-grade mRNA batches.
Get A Free Sample Report With In-Depth Market Insights:
Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Industry Drivers: What’s Behind The Revenue Growth?
The messenger ribonucleic acid (mRNA) manufacturing service market is anticipated to expand due to an increase in clinical trial activity. This activity encompasses all procedures for running and overseeing clinical studies designed to assess medical treatments in human subjects. The growth in clinical trial activity stems from the wider adoption of digital and decentralized trial approaches, facilitating quicker patient enrollment, distant oversight, and more streamlined data gathering across larger groups. Messenger ribonucleic acid (mRNA) manufacturing services support clinical trials by providing swift and adaptable production of mRNA-based therapies, ensuring prompt availability for various trial stages and speeding up drug development. For example, data from the Association of the British Pharmaceutical Industry (ABPI), a UK trade association, revealed that in December 2024, the count of industry-led clinical trials started in the UK rose to 426 in 2023, up from 411 in 2022. Consequently, the growing clinical trial activity is fueling the expansion of the messenger ribonucleic acid (mRNA) manufacturing service market.
Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Segment Analysis: What Are The Core Market Categories?
The messenger ribonucleic acid (mrna) manufacturing service market covered in this report is segmented –
1) By Service Type: Process Development; Analytical Testing; Manufacturing; Fill-Finish; Other Service Types
2) By Scale of Operation: Research And Preclinical Scale; Clinical Scale; Commercial Scale
3) By Application: Vaccines; Therapeutics; Research; Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Other End-Users
Subsegments:
1) By Process Development: Template Design And Optimization; In Vitro Transcription Process Design; Formulation Development; Process Scale-Up And Technology Transfer; Process Validation Support
2) By Analytical Testing: Identity And Purity Testing; Potency And Functional Assays; Impurity And Contaminant Analysis; Stability And Shelf Life Studies; Quality Control Release Testing
3) By Manufacturing: Plasmid Deoxyribonucleic Acid Production; In Vitro Transcription Manufacturing; Enzymatic Capping And Tailoring; Purification And Concentration; Large-Scale Batch Production
4) By Fill-Finish: Aseptic Filling Services; Vial And Syringe Filling; Lyophilization Services; Labeling And Packaging; Cold Chain Handling And Storage
5) By Other Service Types: Regulatory Support Services; Quality Assurance And Documentation; Supply Chain And Logistics Support; Technology Consulting Services; Custom Manufacturing Solutions
#Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the messenger ribonucleic acid (mRNA) manufacturing service market are prioritizing the development of innovative solutions, such as in vitro transcription (IVT), to accelerate the production of high-quality, clinical-grade mRNA for both vaccines and personalized therapies. In vitro transcription (IVT) describes a laboratory method that synthesizes messenger RNA (mRNA) from a DNA template using RNA polymerase enzymes, thereby enabling mRNA to be produced outside of living cells for various research, therapeutic, or vaccine applications. For example, in May 2025, GenScript Biotech Corporation, a biotechnology company based in China, launched a GMP-like mRNA manufacturing service designed to support preclinical studies and research critical for Investigational New Drug (IND) applications. This solution offers high-purity, scalable in vitro transcription (IVT) processes with strict monitoring of key quality attributes like capping efficiency, poly(A) tail length, and impurity profiles. It supports a quick transition from preclinical to clinical stages by allowing for consistent batch-to-batch production, adaptable customization for different mRNA constructs, and reduced development timelines. Moreover, the GMP-like framework ensures readiness for regulatory submission through enhanced traceability, standardized operational procedures, and comprehensive quality documentation, which helps developers minimize risks in later-stage manufacturing and accelerate their clinical progress.
Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Leading Players And Competitive Positioning
Major companies operating in the messenger ribonucleic acid (mrna) manufacturing service market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Biotechnologies, Evonik Industries AG, Lonza Group AG, Charles River Laboratories International Inc., Samsung Biologics Co. Ltd., WuXi Biologics Inc., Recipharm AB, Curia Global Inc., Emergent BioSolutions Inc., AGC Biologics Inc., Corden Pharma International GmbH, Rentschler Biopharma SE, GenScript ProBio, ST Pharm Co. Ltd., etherna Immunotherapies NV, BIOMAY AG., Porton Advanced Solutions Ltd., Wacker Biotech GmbH.
View The Full Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Report:
Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Regional Distribution: Which Areas Power Market Growth?
North America was the largest region in the mRNA manufacturing service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) manufacturing service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
